Last reviewed · How we verify

NCT04121936

The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland

Completed Last updated 6 July 2022
What this trial tests

trial testing There will be no intervention in To Evaluate Lower Urinary Tract Symptoms (LUTS) in Poland in 6,000 participants. Completed in 1 June 2021.

Timeline
11 November 2019
Primary endpoint
31 December 2019
1 June 2021

Quick facts

Lead sponsorJagiellonian University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,000
Start date11 November 2019
Primary completion31 December 2019
Estimated completion1 June 2021
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Jagiellonian University

Who can join

Adults 40 to 100, any sex, with To Evaluate Lower Urinary Tract Symptoms (LUTS) in Poland. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study.
    Przydacz M, Golabek T, Dudek P, Lipinski M, et al · · 2020 · cited 44× · PMID 33188254 · DOI 10.1038/s41598-020-76846-0
  2. Population-Level Prevalence, Bother, and Treatment Behavior for Urinary Incontinence in an Eastern European Country: Findings from the LUTS POLAND Study.
    Przydacz M, Chlosta M, Chlosta P. · · 2021 · cited 12× · PMID 34073165 · DOI 10.3390/jcm10112314
  3. Relationship between Lower Urinary Tract Symptoms and Treatment-Related Behavior in an Eastern European Country: Findings from the LUTS POLAND Study.
    Przydacz M, Dudek P, Golabek T, Chlosta P. · · 2021 · cited 11× · PMID 33477665 · DOI 10.3390/ijerph18020785
  4. Lower Urinary Tract Symptoms and Overactive Bladder in a Large Cohort of Older Poles-A Representative Tele-Survey.
    Przydacz M, Gasowski J, Grodzicki T, Chlosta P. · · 2023 · cited 10× · PMID 37109196 · DOI 10.3390/jcm12082859
  5. Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients.
    Przydacz M, Chlosta M, Golabek T, Chlosta P. · · 2021 · cited 7× · PMID 34071986 · DOI 10.3390/brainsci11060712
  6. Prevalence, Bother and Treatment Behavior Related to Lower Urinary Tract Symptoms and Overactive Bladder among Cardiology Patients.
    Przydacz M, Dudek P, Chlosta P. · · 2020 · cited 3× · PMID 33352663 · DOI 10.3390/jcm9124102
  7. Nocturia at the Population Level in Poland: Prevalence, Bother, Quality of Life, and Treatment-Related Behavior.
    Przydacz M, Chlosta P. · · 2021 · cited 2× · PMID 34068453 · DOI 10.3390/healthcare9050555
  8. Treatment patterns for lower urinary tract symptoms and overactive bladder in an Eastern European country: a nationwide population-representative survey.
    Przydacz M, Chłosta M, Belch Ł, Czech AK, et al · · 2021 · cited 1× · PMID 34729230 · DOI 10.5173/ceju.2021.0087

Verify or expand the search:

Other trials of There will be no intervention

Trials testing the same drug.

Other Jagiellonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04121936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing